Nuzenio

Lead Candidate Deramiocel

Lead Candidate Deramiocel news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 10 publisher sources 100/100 entity strength

Latest news

INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMTCAPR Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:25:00 GMTCAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMTCapricor's August 22 FDA Verdict Looms as Stock Sits 89% Below Peak - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 14:44:58 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - TradingViewTradingView · Tue, 04 Aug 2026 10:36:00 GMTINVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - Business WireBusiness Wire · Tue, 04 Aug 2026 00:00:00 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - theglobeandmail.comtheglobeandmail.com · Mon, 03 Aug 2026 19:10:00 GMTReceptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets - genengnews.comgenengnews.com · Mon, 03 Aug 2026 11:00:49 GMT

Timeline

Fri, 07 Aug 2026 07:00:00 GMTINVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR - Sahm
Thu, 06 Aug 2026 11:25:00 GMTCAPR Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
Thu, 06 Aug 2026 07:00:00 GMTCAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - Sahm
Wed, 05 Aug 2026 14:44:58 GMTCapricor's August 22 FDA Verdict Looms as Stock Sits 89% Below Peak - AD HOC NEWS
Tue, 04 Aug 2026 10:36:00 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - TradingView
Tue, 04 Aug 2026 00:00:00 GMTINVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire

Related explainers

PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lead Candidate Deramiocel.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.